Validation of physician certified verbal autopsy using conventional autopsy: a large study of adult non-external causes of death in a metropolitan area in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
ANDRE, Carmen Diva Saldiva de
BIERRENBACH, Ana Luiza
BARROSO, Lucia Pereira
TANIGUCHI, Mauro T.
MINTO, Catia Martinez
TAKECIAN, Pedro Losco
KAMAURA, Leonardo Tadashi
Citação
BMC PUBLIC HEALTH, v.22, n.1, article ID 748, 11p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Reliable mortality data are essential for the development of public health policies. In Brazil, although there is a well-consolidated universal system for mortality data, the quality of information on causes of death (CoD) is not even among Brazilian regions, with a high proportion of ill-defined CoD. Verbal autopsy (VA) is an alternative to improve mortality data. This study aimed to evaluate the performance of an adapted and reduced version of VA in identifying the underlying causes of non-forensic deaths, in Sao Paulo, Brazil. This is the first time that a version of the questionnaire has been validated considering the autopsy as the gold standard. Methods The performance of a physician-certified verbal autopsy (PCVA) was evaluated considering conventional autopsy (macroscopy plus microscopy) as gold standard, based on a sample of 2060 decedents that were sent to the Post-Mortem Verification Service (SVOC-USP). All CoD, from the underlying to the immediate, were listed by both parties, and ICD-10 attributed by a senior coder. For each cause, sensitivity and chance corrected concordance (CCC) were computed considering first the underlying causes attributed by the pathologist and PCVA, and then any CoD listed in the death certificate given by PCVA. Cause specific mortality fraction accuracy (CSMF-accuracy) and chance corrected CSMF-accuracy were computed to evaluate the PCVA performance at the populational level. Results There was substantial variability of the sensitivities and CCC across the causes. Well-known chronic diseases with accurate diagnoses that had been informed by physicians to family members, such as various cancers, had sensitivities above 40% or 50%. However, PCVA was not effective in attributing Pneumonia, Cardiomyopathy and Leukemia/Lymphoma as underlying CoD. At populational level, the PCVA estimated cause specific mortality fractions (CSMF) may be considered close to the fractions pointed by the gold standard. The CSMF-accuracy was 0.81 and the chance corrected CSMF-accuracy was 0.49. Conclusions The PCVA was efficient in attributing some causes individually and proved effective in estimating the CSMF, which indicates that the method is useful to establish public health priorities.
Palavras-chave
Verbal autopsy, Mortality surveillance, Natural death, Death certification, Underlying cause of death, Vital statistics
Referências
  1. Barrozo LV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232074
  2. Bernardi FDC, 2005, J CLIN PATHOL, V58, P1261, DOI 10.1136/jcp.2005.027953
  3. CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213
  4. Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x
  5. DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5
  6. Flaxman AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178085
  7. Flaxman AD, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0061-1
  8. Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29
  9. França Elisabeth Barboza, 2014, Rev. bras. epidemiol., V17, P119, DOI 10.1590/1415-790X201400010010ENG
  10. Karat AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174097
  11. King C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0115-5
  12. King G, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-19
  13. Kotovicz F, 2008, CLINICS, V63, P581, DOI 10.1590/S1807-59322008000500003
  14. Kumar V, 2013, ROBBINS BASIC PATHOL
  15. Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32
  16. Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7
  17. Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
  18. Menendez C, 2021, GATES OPEN RES, V4, P55
  19. Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059
  20. Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
  21. Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-28
  22. Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27
  23. Rosai J., ROSAI ACKERMANS SURG, V11th
  24. Serina P, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0105-1
  25. Serina P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0528-8
  26. Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x
  27. Thomas LM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000639
  28. World Health Organization, 2004, ICD 10 INT CLASSIFIC
  29. Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181